Hologic cleared to integrate WHO risk calculator with bone density system
The FDA has cleared Hologic to incorporate the World Health Organization’s (WHO) 10-year fracture risk calculator, FRAX, into its bone densitometer systems.
The WHO Collaborating Centre for Metabolic Bone Diseases, located at the University of Sheffield Medical School, England, under the leadership of John Kanis, MD, developed FRAX as a tool to help healthcare providers identify and proactively treat patients with a high risk of bone fractures due to low bone mass and other risk factors within a period of 10 years, according to the company.
The Bedford, Mass.-based Hologic, a provider of diagnostic and digital imaging systems directed towards women’s health, said it has built the technology into its Discovery and Explorer bone densitometer systems.
By combining eleven of the highest risk factors, including age, personal history of factures and family history of fractures, plus country-specific life expectancy and country-specific fracture data, FRAX identifies patients who are at high risk of fracture but would not be candidates for preventative therapy using the traditional T-score.
The WHO Collaborating Centre for Metabolic Bone Diseases, located at the University of Sheffield Medical School, England, under the leadership of John Kanis, MD, developed FRAX as a tool to help healthcare providers identify and proactively treat patients with a high risk of bone fractures due to low bone mass and other risk factors within a period of 10 years, according to the company.
The Bedford, Mass.-based Hologic, a provider of diagnostic and digital imaging systems directed towards women’s health, said it has built the technology into its Discovery and Explorer bone densitometer systems.
By combining eleven of the highest risk factors, including age, personal history of factures and family history of fractures, plus country-specific life expectancy and country-specific fracture data, FRAX identifies patients who are at high risk of fracture but would not be candidates for preventative therapy using the traditional T-score.